KRAS and pancreatic neoplasm: We explored in silico the transcriptomics profiles for the 11 selected genes by RNA‐Seq data from the CCLE joining for each colorectal and pancreatic tumor type the most common KRAS missense mutations (hotspot 12, 13, 61) [7].